Term: | N-\{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl\}-G-dR-G-dD-dD-dD-NH2 |
|
Accession: | CHEBI:138409
|
browse the term
|
Definition: | A hexapeptide consisting of N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazol-5-yl]carbonyl}glycine, D-arginine, glycine, D-alpha-aspartic acid, D-alpha-aspartic acid, and D-alpha-aspartic 1-amide residues coupled in sequence. An angiotensin II type 2 receptor agonist. |
Synonyms: | exact_synonym: | N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazol-5-yl]carbonyl}glycyl-D-arginylglycyl-D-alpha-aspartyl-D-alpha-aspartyl-D-alpha-asparagine |
| related_synonym: | Formula=C37H46N14O14S; InChI=1S/C37H46N14O14S/c1-16-29(66-37(44-16)49-31(61)17-6-3-2-4-7-17)19-10-23(51-50-19)33(63)43-14-24(52)45-18(8-5-9-41-36(39)40)32(62)42-15-25(53)46-21(12-27(56)57)34(64)48-22(13-28(58)59)35(65)47-20(30(38)60)11-26(54)55/h2-4,6-7,10,18,20-22H,5,8-9,11-15H2,1H3,(H2,38,60)(H,42,62)(H,43,63)(H,45,52)(H,46,53)(H,47,65)(H,48,64)(H,50,51)(H,54,55)(H,56,57)(H,58,59)(H4,39,40,41)(H,44,49,61)/t18-,20-,21-,22-/m1/s1; InChIKey=OPFJDXRVMFKJJO-ZHHKINOHSA-N; N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-GdRGdDdDdD-NH2; N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-Gly-D-Arg-Gly-D-alpha-Asp-D-alpha-Asp-D-alpha-Asp-NH2; SMILES=C(CNC(=O)[C@H](NC(=O)CNC(C1=CC(=NN1)C=2SC(=NC2C)NC(C3=CC=CC=C3)=O)=O)CCCNC(N)=N)(N[C@@H](C(N[C@@H](C(N[C@@H](C(N)=O)CC(=O)O)=O)CC(=O)O)=O)CC(=O)O)=O; cmpd21; compound 21 |
| xref: | PMID:22184324; PMID:22802221; PMID:23164706; PMID:24041944; PMID:24329698; PMID:24361310; PMID:24508710; PMID:24687998; PMID:24752645; PMID:24914880; PMID:25186297; PMID:25304472; PMID:25398877; PMID:25560767; PMID:25753301; PMID:25776077; PMID:26783414; PMID:27168137; PMID:28099262; PMID:28192099; PMID:28456626; PMID:28711702; Reaxys:25999889 |
|
|